American Vietnamese Biotech (HSTC:AMV) Days Payable : 0.00 (As of . 20)

View and export this data going back to 2009. Start your Free Trial

What is American Vietnamese Biotech Days Payable?

American Vietnamese Biotech's average Accounts Payable for the three months ended in . 20 was ₫0.00 Mil. American Vietnamese Biotech's Cost of Goods Sold for the three months ended in . 20 was ₫0.00 Mil.

The historical rank and industry rank for American Vietnamese Biotech's Days Payable or its related term are showing as below:

HSTC:AMV's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.12
* Ranked among companies with meaningful Days Payable only.

American Vietnamese Biotech's Days Payable stayed the same from . 20 (0.00) to . 20 (0.00). stayed the same

American Vietnamese Biotech Days Payable Historical Data

The historical data trend for American Vietnamese Biotech's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Vietnamese Biotech Days Payable Chart

American Vietnamese Biotech Annual Data

Trend

Days Payable

American Vietnamese Biotech Quarterly Data

Days Payable

Competitive Comparison of American Vietnamese Biotech's Days Payable

For the Biotechnology subindustry, American Vietnamese Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Vietnamese Biotech's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Vietnamese Biotech's Days Payable distribution charts can be found below:

* The bar in red indicates where American Vietnamese Biotech's Days Payable falls into.

American Vietnamese Biotech Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

American Vietnamese Biotech's Days Payable for the fiscal year that ended in . 20 is calculated as

	Days Payable (A: . 20 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: . 20 )	+	Accounts Payable (A: . 20 ))	/	count )	/	Cost of Goods Sold (A: . 20 )	*	Days in Period
=	( (	+	)	/	1 )	/		*	365
=	0					/		*	365
=	N/A

American Vietnamese Biotech's Days Payable for the quarter that ended in . 20 is calculated as:

	Days Payable (Q: . 20 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: . 20 )	+	Accounts Payable (Q: . 20 ))	/	count )	/	Cost of Goods Sold (Q: . 20 )	*	Days in Period
=	( (	+	)	/	1 )	/		*	365 / 4
=	0					/		*	365 / 4
=	N/A

American Vietnamese Biotech Days Payable Related Terms

Thank you for viewing the detailed overview of American Vietnamese Biotech's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

American Vietnamese Biotech (HSTC:AMV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 Road 13, Block DC Song Da, Thu Duc Ward, Ho Chi Minh, VNM

Website

http://www.amvibiotech.com

American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments and chemicals; producing and trading vaccines and medical biological products; real estate business and financial investment.